Accuray

Founded in Sunnyvale, California, Accuray Inc. is dedicated to developing precise tumor treatment solutions aimed at improving patient outcomes. The company's core mission is to advance the field of radiosurgery and radiation therapy through innovative technologies. Accuray offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system, which is used for treating primary and metastatic tumors outside the brain. Their market focus spans across the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the rest of the Asia Pacific region.

Accuray has garnered attention for its partnerships and innovations in the medical technology field. Notable affiliated individuals include key researchers and medical professionals who have contributed to the development of their systems. The company has achieved significant milestones, such as hosting successful user meetings in Northern Europe and being featured in various industry news outlets like ISRS and ESTRO. Accuray's impact is evident in its widespread adoption and the improved treatment outcomes for patients globally.